NewsBenzingaPharmaCyte Biotech Maintains More Than $17M In Cash With Total Assets Over $36M PharmaCyte Biotech Maintains More Than $17M In Cash With Total Assets Over $36M Benzinga 2026.11.13 14:20 (GMT+0) Open on Benzinga Other news OpenAI CEO Sam Altman says it’s ‘hard to imagine the AI industry without Jensen’ Nvidia’s Jensen Huang Scandal Just Got More Expensive Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic. Sony’s updated turntable is an easy entry into the world of vinyl As Tesla Plans to Roll Out the Cybercab for Individual Use, TSLA Stock Is a Tough Nut to Crack How the Anthropic IPO stacks up against SpaceX
Billionaire Brad Gerstner Is Betting $5 Billion on the Anthropic IPO. The Smart Money Is Shrugging Off the AI Panic.